BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30145982)

  • 41. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Multidisciplinary management of skull base and craniocervical chordoma].
    Maier W; Lohnstein PU; Rosahl SK; Tatagiba M; Schipper J
    Laryngorhinootologie; 2006 Apr; 85(4):272-8. PubMed ID: 16646108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical outcome of sacral chordoma with carbon ion radiotherapy compared with surgery.
    Nishida Y; Kamada T; Imai R; Tsukushi S; Yamada Y; Sugiura H; Shido Y; Wasa J; Ishiguro N
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):110-6. PubMed ID: 20400242
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Three-Dimensional Volume Imaging to Increase the Accuracy of Surgical Management in a Case of Recurrent Chordoma of the Clivus.
    Gomes JPP; Veloso JRC; Altemani AMAM; Chone CT; Altemani JMC; de Freitas CF; Lima CSP; Braz-Silva PH; Costa ALF
    Am J Case Rep; 2018 Oct; 19():1168-1174. PubMed ID: 30275439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure.
    Noël G; Habrand JL; Jauffret E; de Crevoisier R; Dederke S; Mammar H; Haie-Méder C; Pontvert D; Hasboun D; Ferrand R; Boisserie G; Beaudré A; Gaboriaud G; Guedea F; Petriz L; Mazeron JJ
    Strahlenther Onkol; 2003 Apr; 179(4):241-8. PubMed ID: 12707713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct intratumoral chemotherapy with carboplatin and epinephrine in a recurrent cervical chordoma: case report.
    Guiu S; Guiu B; Feutray S; Chauffert B
    Neurosurgery; 2009 Sep; 65(3):E629-30; discussion E630. PubMed ID: 19687674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chordoma and malignant fibrous histiocytoma. Evidence for transformation.
    Belza MG; Urich H
    Cancer; 1986 Sep; 58(5):1082-7. PubMed ID: 2425929
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unexpected benefit from an 'old' metronomic chemotherapy regimen in advanced chordoma.
    Spalato Ceruso M; Napolitano A; Silletta M; Vincenzi B
    BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31160300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chordoma: combined therapy with radiation and surgery: case report and new operative approach.
    Pearlman AW; Singh RK; Hoppenstein R; Wilder J
    Bull Hosp Joint Dis; 1972 Apr; 33(1):47-57. PubMed ID: 5025919
    [No Abstract]   [Full Text] [Related]  

  • 50. Durable stabilization of three chordoma cases by bevacizumab and erlotinib.
    Asklund T; Sandström M; Shahidi S; Riklund K; Henriksson R
    Acta Oncol; 2014 Jul; 53(7):980-4. PubMed ID: 24456503
    [No Abstract]   [Full Text] [Related]  

  • 51. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
    Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
    Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chordomas of the craniocervical junction: follow-up review and prognostic factors.
    Colli B; Al-Mefty O
    J Neurosurg; 2001 Dec; 95(6):933-43. PubMed ID: 11765837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent chordoma of the L2 vertebra: a case report.
    Heylen S; Michielsen J; Mahieu G; Somville J
    Acta Orthop Belg; 2010 Jun; 76(3):416-9. PubMed ID: 20698468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A Case of Chordoma of the Sacrum Treated with Pazopanib].
    Shinji A; Okada S; Nakamura T
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):267-9. PubMed ID: 27067697
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chordomas of the Skull Base, Mobile Spine, and Sacrum: An Epidemiologic Investigation of Presentation, Treatment, and Survival.
    Zuckerman SL; Bilsky MH; Laufer I
    World Neurosurg; 2018 May; 113():e618-e627. PubMed ID: 29486315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment modalities and prognostic factors of chordoma in the skull base].
    Qian LT; Liu XF; Li YX
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):635-7. PubMed ID: 16438879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Unusual course of sacrococcygeal chordoma].
    Nazemi R; Lichtinger TK; Müller RT
    Zentralbl Chir; 2001 Sep; 126(9):710-2. PubMed ID: 11699289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical resection of skull-base chordomas: experience in case selection for surgical approach according to anatomical compartments and review of the literature.
    Shimony N; Gonen L; Shofty B; Abergel A; Fliss DM; Margalit N
    Acta Neurochir (Wien); 2017 Oct; 159(10):1835-1845. PubMed ID: 27924417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Sacro-coccygeal chordoma: review of literature and case report].
    Binazzi R
    Arch Putti Chir Organi Mov; 1980; 30():413-26. PubMed ID: 7036950
    [No Abstract]   [Full Text] [Related]  

  • 60. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.
    Stacchiotti S; Casali PG; Lo Vullo S; Mariani L; Palassini E; Mercuri M; Alberghini M; Pilotti S; Zanella L; Gronchi A; Picci P
    Ann Surg Oncol; 2010 Jan; 17(1):211-9. PubMed ID: 19847568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.